After EGFR binds to ligands, both extracellular and intracellular domains of receptor tyrosine kinase undergo dynamic conformational changes, resulting in common phenotypes in tumor cells, such as cell evasion of apoptosis, proliferation, invasion, and metastasis. The gene discussed is EGFR; the disease is neoplasm.